Antifungal Prophylaxis in Lung Transplantation—A World‐wide Survey von Neoh, C. F., Snell, G. I., Kotsimbos, T., Levvey, B., Morrissey, C. O., Slavin, M. A., Stewart, K., Kong, D. C. M.

Volltext

The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports von Jeong, W., Keighley, C., Wolfe, R., Lee, W.L., Slavin, M.A., Kong, D.C.M., Chen, S.C.-A.

Volltext

Factors influencing the cost of prosthetic joint infection treatment von Peel, T.N, Cheng, A.C, Lorenzo, Y.P, Kong, D.C.M, Buising, K.L, Choong, P.F.M

Volltext

Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study von Lim, Ching Jou, Cheng, Allen C, Kennon, Jacqueline, Spelman, Denis, Hale, Dayna, Melican, Gabrielle, Sidjabat, Hanna E, Paterson, David L, Kong, David C M, Peleg, Anton Y

Volltext

Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey von Khanina, A, Urbancic, K F, Haeusler, G M, Kong, D C M, Douglas, A P, Tio, S Y, Worth, L J, Slavin, M A, Thursky, K A

Volltext

Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool von Khanina, A, Douglas, A P, Yeoh, D K, So, M, Abbotsford, J, Spelman, T, Kong, D C M, Slavin, M A, Thursky, K A

Volltext

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014 von Chau, M. M., Kong, D. C. M., van Hal, S. J., Urbancic, K., Trubiano, J. A., Cassumbhoy, M., Wilkes, J., Cooper, C. M., Roberts, J. A., Marriott, D. J. E., Worth, L. J.

Volltext

Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay von CHEAH, A. L. Y., SPELMAN, T., PEEL, T., HOWDEN, B. P., SPELMAN, D., GRAYSON, M. L., NATION, R. L., KONG, D. C. M.

Volltext

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization von Cheah, A.A.Y., Spelman, T., Liew, D., Peel, T., Howden, B.P., Spelman, D., Grayson, M.L., Nation, R.L., Kong, D.D.M.

Volltext

Qualitative study of the factors impacting antimicrobial stewardship programme delivery in regional and remote hospitals von Bishop, J.L., Schulz, T.R., Kong, D.C.M., Buising, K.L.

Volltext

Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics von Wu, D B C, Chaiyakunapruk, N, Pratoomsoot, C, Lee, K K C, Chong, H Y, Nelson, R E, Smith, P F, Kirkpatrick, C M, Kamal, M A, Nieforth, K, Dall, G, Toovey, S, Kong, D C M, Kamauu, A, Rayner, C R

Volltext

Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey von Neoh, C. F., Senol, E., Kara, A., Dinleyici, E. C., Turner, S. J., Kong, D. C. M.

Volltext

Preemptive treatment with voriconazole in lung transplant recipients von Neoh, C.F., Snell, G.I., Levvey, B., Kotsimbos, T., Morrissey, C.O., Slavin, M.A., Stewart, K., Kong, D.C.M.

Volltext

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia von Al-Badriyeh, Daoud, Liew, Danny, Stewart, Kay, Kong, David C. M.

Volltext

Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey von Turner, S.J, Senol, E, Kara, A, Al-Badriyeh, D, Kong, D.C.M, Dinleyici, E.C

Volltext

Quantification of voriconazole in human bronchoalveolar lavage fluid using high-performance liquid chromatography with fluorescence detection von Heng, S.C., Nation, R.L., Levvey, B., Snell, G.I., Slavin, M.A., Kong, D.C.M.

Volltext

CsA 2-h concentration correlates best with area under the concentration-time curve after allo-SCT compared with trough CsA von Kong, D C M, Shuttleworth, P, Bailey, M, Grigg, A

Volltext

Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders von Worth, L. J., Blyth, C. C., Booth, D. L., Kong, D. C. M., Marriott, D., Cassumbhoy, M., Ray, J., Slavin, M. A., Wilkes, J. R.

Volltext

Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis von Neoh, C. F., Liew, D., Slavin, M. A, Marriott, D., Chen, S. C.-A., Morrissey, O., Stewart, K., Kong, D. C. M.

Volltext

Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey von Turner, S. J., Senol, E., Kara, A., Al-Badriyeh, D., Dinleyici, E. C., Kong, D. C. M.

Volltext